We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Experimental Drug Cancels Effect from Key Intellectual Disability Gene

News   Apr 28, 2016

 
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
 
 
Advertisement
 

RELATED ARTICLES

Two Is Better Than One for Novel COVID-19 Mouse Model

News

Researchers have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

READ MORE

A Novel Way To Deliver More Drugs Through the Skin

News

By applying “temporal pressure” to the skin of mice, researchers have shown that the pressure technique can be used to create a novel drug delivery approach.

READ MORE

Team Develops Synthetic Blood-Thinner With No Bleeding Side Effects

News

Scientists have developed a highly selective and highly stable synthetic blood-thinning molecule that, unlike others, doesn’t cause bleeding adverse effects.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE